A link between c-kit gain of function mutations and neoplasms such as mast cell tumors, gastrointestinal stromal tumors, seminoma/dysgerminoma and small cell lung carcinoma has been reported [6,8,16,17]. This evidence concerns the gene KIT and mast cell neoplasm.